Clinical Trial Update: Sulforaphane in Treating Patients With Recurrent Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating sulforaphane for recurrent prostate cancer has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Adenocarcinoma of the Prostate, Recurrent Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-03-03